18.7.2007   

EN

Official Journal of the European Union

C 164/37


Notice to users of controlled substances in the European Union allowed for essential uses in the Community in 2008 under Regulation (EC) No 2037/2000 of the European Parliament and of the Council on ‘substances that deplete the ozone layer’

(2007/C 164/10)

I.

This Notice concerns the following substances:

Group I:

CFC 11, 12, 113, 114 or 115

Group II:

other fully halogenated CFCs

Group III:

halon 1211, 1301 or 2402

Group IV:

carbon tetrachloride

Group V:

1,1,1-trichloroethane

Group VI:

methyl bromide

Group VII:

hydrobromofluorocarbons

Group VIII:

hydrochlorofluorocarbons

Group IX:

bromochloromethane

II.

This notice is addressed to users that intend to:

1.

use the above substances within the Community for the manufacture of Metered Dose Inhalers (MDIs);

2.

acquire the above substances for laboratory and analytical uses directly from a producer or by import into the Community and not from any distributor of the substances inside the Community.

III.

Controlled substances for essential uses may be obtained from production within the Community and, if necessary, by import from sources outside the Community.

IV.

Decision IV/25 of the Parties to the Montreal Protocol on Substances that Deplete the Ozone Layer sets out criteria and a procedure for determining ‘essential uses’ for which continued production and consumption are allowed after phase-out.

V.

Article 3(1) of Regulation (EC) No 2037/2000 of the European Parliament and of the Council (1) requires the determination of quantities for essential uses of the above-mentioned controlled substances which may be permitted in the Community in 2008 if no adequate alternatives are available and in accordance with Decision IV/25 of the Parties to the Montreal Protocol.

VI.

The Parties to the Montreal Protocol may take a Decision in September 2007 that authorises the maximum levels of production and consumption necessary to satisfy essential uses of CFCs in 2007 for metered dose inhalers (MDIs) for the treatment of asthma and chronic obstructive pulmonary diseases as specified in Annex I, subject to the conditions established by the Meeting of the Parties in paragraph 2 of its Decision VII/28.

VII.

Decision XV/8 of the Parties to the Montreal Protocol authorises the production and consumption necessary to satisfy essential uses of controlled substances listed in Annexes A, B and C (Group II and III substances) of the Montreal Protocol for laboratory and analytical uses as listed in Annex IV to the report of the Seventh Meeting of the Parties, subject to the conditions set out in Annex II to the report of the Sixth Meeting of the Parties.

VIII.

In accordance with Decision X/19 of the Parties to the Montreal Protocol, the purity of controlled substances for laboratory and analytical uses should be at least 99,0 % for 1,1,1-trichloroethane and 99,5 % for CFCs and carbon tetrachloride. These high purity substances and mixtures containing controlled substances shall be supplied only in re-closable containers or high pressure cylinders smaller than three litres or in 10 millilitre or smaller glass ampoules, marked clearly as substances that deplete the ozone layer, restricted to laboratory and analytical uses and specifying that used or surplus substances should be collected and recycled wherever possible. The material should be destroyed following the procedures described in Article 16(1) of the Regulation if recycling is not practical.

IX.

Adopted in December 2005, Decision XVII/10 of the Parties to the Montreal Protocol authorises the production and consumption necessary to satisfy essential uses of methyl bromide, the controlled substance listed in Annexe E (Group I substances) of the Montreal Protocol, for laboratory and analytical uses as listed in Annex IV to the report of the Seventh Meeting of the Parties, subject to the conditions set out in Annex II to the report of the Sixth Meeting of the Parties. The categories of permitted laboratory and analytical critical use of methyl bromide are listed in paragraph 2 of Decision XVIII/15. The uses listed in sub-paragraphs (a) and (c) of paragraph 6 of Decision VII/11 and Decision XI/15 are excluded from the allowed laboratory and analytical uses.

X.

More information, including the texts of the relevant Decisions quoted here above (Decisions IV/25, XI/15, XV/8, XVI/16 XVII/10 and XVIII/15) can be found at:

http://ec.europa.eu/environment/ozone/pdf/2006_lab.pdf

XI.

The procedure for allocating quantities of controlled substances for the above essential uses carried out under the Regulation (EC) No 2037/2000 and Regulation (EC) No 2038/2000 of the European Parliament and the Council (2) is the following:

1.

An undertaking that has not been issued with a quota in 2007 and that requests consideration by the Commission for an essential use quota for the period 1 January 2008 to 31 December 2008 should make itself known to the Commission no later than 1 September 2007 by submitting the registration form available online at:

http://ec.europa.eu/environment/ozone/ods_documents/ods_registration_form.doc

After their registration in the ODS-database it is necessary to follow the procedure described in 2.

2.

Essential use applications may be made by any user of substances listed at the beginning of this Notice.

For CFCs for use in MDIs, all registered undertakings will receive an application form from the Commission.

For Laboratory Uses, each applicant should apply by completing the relevant form online via the ODS-database available at:

http://ec.europa.eu/environment/ozone/ods.htm

In addition to the online submission a signed print of the import declaration form needs to be sent to the Commission:

European Commission

Directorate-General Environment

Unit ENV.C.4 — Industrial Emissions & Protection of the ozone layer

BU-5 2/200

B-1049 Brussels

Fax (32-2) 292 06 92

E-mail: env-ods@ec.europa.eu

A copy of the application should also be sent to the competent authority of the Member State (refer to Annex II for appropriate address).

XII.

Only applications received by 1 September 2007 will be considered by the Commission.

XIII.

The Commission will issue quotas to those users and shall notify them of the use for which they have authorisation, the substance they are authorised to use and the quantity of the controlled substances concerned.

XIV.

Following the above procedure, the Commission on the basis of a Decision will notify applicants of the quantities of controlled substances authorised in the Community for 2008 for which production and importation of controlled substances will be permitted.

XV.

Those users holding an essential use quota for a controlled substance for 2007 will be able to make a request to a Community producer via the ODS-database or, if necessary, request an import licence from the Commission for a controlled substance up to their quota limit. The producer must be authorised by the competent authority of the Member State in which its relevant production is situated to produce the controlled substance for meeting that licensed demand. The competent authority of the Member State shall notify the Commission well in advance of any such authorisation.


(1)  OJ L 244 of 29.9.2000, p. 1 as last amended by Council Regulation (EC) No 1791/2006 (OJ L 363 of 20.12.2006, p. 1).

(2)  OJ L 244 of 29.9.2000, p. 25.


ANNEX I

Substances covered

Group

Substances

Ozone-depleting potential (1)

Group I

CFCl3

(CFC 11)

1,0

CF2Cl2

(CFC 12)

1,0

C2F3Cl3

(CFC 113)

0,8

C2F4Cl2

(CFC 114)

1,0

C2F5Cl

(CFC 115)

0,6

Group II

CF3Cl

(CFC 13)

1,0

C2FCl5

(CFC 111)

1,0

C2F2Cl4

(CFC 112)

1,0

C3FCl7

(CFC 211)

1,0

C3F2Cl6

(CFC 212)

1,0

C3F3Cl5

(CFC 213)

1,0

C3F4Cl4

(CFC 214)

1,0

C3F5Cl3

(CFC 215)

1,0

C3F6Cl2

(CFC 216)

1,0

C3F7Cl

(CFC 217)

1,0

Group III

CF2BrCl

(halon 1211)

3,0

CF3Br

(halon 1301)

10,0

C2F4Br2

(halon 2402)

6,0

Group IV

CCl4

(carbon tetrachloride)

1,1

Group V

C2H3Cl3  (2)

(1,1,1-trichloroethane)

0,1

Group VI

CH3Br

(methyl bromide)

0,6

Group VII

CHFBr2

 

1,00

CHF2Br

 

0,74

CH2FBr

 

0,73

C2HFBr4

 

0,8

C2HF2Br3

 

1,8

C2HF3Br2

 

1,6

C2HF4Br

 

1,2

C2H2FBr3

 

1,1

C2H2F2Br2

 

1,5

C2H2F3Br

 

1,6

C2H3FBr2

 

1,7

C2H3F2Br

 

1,1

C2H4FBr

 

0,1

C3HFBr6

 

1,5

C3HF2Br5

 

1,9

C3HF3Br4

 

1,8

C3HF4Br3

 

2,2

C3HF5Br2

 

2,0

C3HF6Br

 

3,3

C3H2FBr5

 

1,9

C3H2F2Br4

 

2,1

C3H2F3Br3

 

5,6

C3H2F4Br2

 

7,5

C3H2F5Br

 

1,4

C3H3FBr4

 

1,9

C3H3F2Br3

 

3,1

C3H3F3Br2

 

2,5

C3H3F4Br

 

4,4

C3H4FBr3

 

0,3

C3H4F2Br2

 

1,0

C3H4F3Br

 

0,8

C3H5FBr2

 

0,4

C3H5F2Br

 

0,8

C3H6FBr

 

0,7

Group VIII

CHFCl2

(HCFC 21) (3)

0,040

CHF2Cl

(HCFC 22) (3)

0,055

CH2FCl

(HCFC 31)

0,020

C2HFCl4

(HCFC 121)

0,040

C2HF2Cl3

(HCFC 122)

0,080

C2HF3Cl2

(HCFC 123) (3)

0,020

C2HF4Cl

(HCFC 124) (3)

0,022

C2H2FCl3

(HCFC 131)

0,050

C2H2F2Cl2

(HCFC 132)

0,050

C2H2F3Cl

(HCFC 133)

0,060

C2H3FCl2

(HCFC 141)

0,070

CH3CFCl2

(HCFC 141b) (3)

0,110

C2H3F2Cl

(HCFC 142)

0,070

CH3CF2Cl

(HCFC 142b) (3)

0,065

C2H4FCl

(HCFC 151)

0,005

C3HFCl6

(HCFC 221)

0,070

C3HF2Cl5

(HCFC 222)

0,090

C3HF3Cl4

(HCFC 223)

0,080

C3HF4Cl3

(HCFC 224)

0,090

C3HF5Cl2

(HCFC 225)

0,070

CF3CF2CHCl2

(HCFC 225ca) (3)

0,025

CF2ClCF2CHClF

(HCFC 225cb) (3)

0,033

C3HF6Cl

(HCFC 226)

0,100

C3H2FCl5

(HCFC 231)

0,090

C3H2F2Cl4

(HCFC 232)

0,100

C3H2F3Cl3

(HCFC 233)

0,230

C3H2F4Cl2

(HCFC 234)

0,280

C3H2F5Cl

(HCFC 235)

0,520

C3H3FCl4

(HCFC 241)

0,090

C3H3F2Cl3

(HCFC 242)

0,130

C3H3F3Cl2

(HCFC 243)

0,120

C3H3F4Cl

(HCFC 244)

0,140

C3H4FCl3

(HCFC 251)

0,010

C3H4F2Cl2

(HCFC 252)

0,040

C3H4F3Cl

(HCFC 253)

0,030

C3H5FCl2

(HCFC 261)

0,020

C3H5F2Cl

(HCFC 262)

0,020

C3H6FCl

(HCFC 271)

0,030

Group IX

CH2BrCl

Halon 1011/bromochloromethane

0,120


(1)  These ozone-depleting potentials are estimates based on existing knowledge and will be reviewed and revised periodically in the light of decisions taken by the Parties to the Montreal Protocol on Substances that Deplete the Ozone Layer.

(2)  This formula does not refer to 1,1,2-trichloroethane.

(3)  Identifies the most commercially-viable substance as prescribed in the Protocol.


ANNEX II

Competent authorities of the Member States

BELGIQUE/BELGÏE

Mr Alain Wilmart

Ministère Fédéral des Affaires Sociales de la Santé Publique et de l'Environnement

Place Victor Horta, 40 — Bte 10

B-1060 Bruxelles

БЪЛГАРИЯ

Irina Sirashka

Global Atmospheric Processes Dept

Ministry of Environment and Water

22 Maria-Louisa Str.

BG-1000 Sofia

ČESKÁ REPUBLIKA

Mr Jakub Achrer

Ministry of the Environment of the Czech Republik

Air Pollution Prevention Department

Vršovická 65

CZ-100 10 Prague 10

DANMARK

Mr Mikkel Aaman Sørensen

Miljøstyrelsen (EPA)

Strandgade 29

DK-1401 Copenhagen K

DEUTSCHLAND

Mr Rolf Engelhardt

Ministry for Environment

Dept. IG II 1

P.O. Box 12 06 29

D-53048 Bonn

EESTI

Ms Valentina Laius

Ministry of the Environment of the Republic of Estonia

Narva mnt 7a

EE-Tallinn 15172

ΕΛΛΑΣ

Ms Sotiria Koloutsou-Vakakis

Environmental Engineer Ph.D.

Ministry for the Environment, Physical Planning and Public Works, Directorate for the Environment — Department of Air Quality

147 Patission

GR-112 51 Athens

ESPAÑA

Mr Alberto Moral Gonzalez

Ministerio de Medio Ambiente

Subdirección General de Calidad Ambiental

Pza San Juan de la Cruz s/n

E-28071 Madrid

FRANCE

Mr Vincent Szleper

Ministère de l'Écologie

DPPR/BSPC

20, avenue de Ségur

F-75302 Paris 07 SP

IRELAND

Mr David O'Sullivan

Inspector (Environment)

Dept of Environment, Heritage and Local Government Custom House

Dublin 1

Ireland

ITALIA

Mr Alessandro Giuliano Peru

Ministry for the Environment, Land and Sea

DG per la Ricerca ambientale e lo sviluppo

Via Cristoforo Colombo, 44

I-00147 Roma

ΚΥΠΡΟΣ

Dr. Charalambos Hajipakkos

Environment Service

Ministry of Agriculture, Natural Resources and Environment

CY-Nicosia

LATVIJA

Mr Armands Plate

Ministry of Environment

Environmental Protection Department

Peldu Iela 25

LV-1494 Riga

LIETUVA

Ms Marija Teriosina

Ministry of Environment

Chemicals Management Division

A. Jaksto 4/9

LT-2694 Vilnius

LUXEMBOURG

Mr Pierre Dornseiffer

Administration de l'Environnement

Division Air/Bruit

16, rue Eugène Ruppert

L-2453 Luxembourg

MAGYARORSZÁG

Mr Róbert Tóth

Ministry of Environment and Water

Department of Environmental Development

Fő utca 44-50

H-1011 Budapest

MALTA

Ms Charmaine Ajao Vassallo

Environment and Planning Authority

Environment Protection Directorate

Industrial Estate Kordin

Paola

NEDERLAND

Ms Gudi Alkemade

Climate Change Directorate

Ministry of Environment

PO Box 30945

2500 GX Den Haag

Nederland

ÖSTERREICH

Mr Paul Krajnik

Ministry of the Agriculture, Forestry, Environment and Water Management

Chemicals Department

Stubenbastei 5

A-1010 Wien

POLSKA

Mr Janusz Kozakiewicz

Industrial Chemistry Research Institute

Ozone Layer Protection Unit

8, Rydygiera Street

PL-01-793 Warsaw

PORTUGAL

Dra. Cristina Vaz Nunes

Ministry of Environment, Territorial Planning and Regional Development

Institute of Environment

Rua da Murgueira 9/9A — Zambujal Ap. 785

P-2611-865 Amadora

ROMANIA

Rodica Ella Morohoi

Ministry of Environment and Waters Management

12, Libertății Bv, District 5

Bucharest

SLOVENIJA

Ms Irena Malešič

Ministry of the Environment and Spacial Planning

Environmental Agency of the Republic of Slovenia

Vojkova 1b

SLO-1000 Ljubljana

SLOVENSKO

Mr Lubomir Ziak

Ministry of the Environment

Air Protection Department

Nam. L. Štúra 1

SK-812 35 Bratislava

SUOMI/FINLAND

Mrs Eliisa Irpola

Finnish Environment Institute

P.O.Box 140

FIN-00251 Helsinki

SVERIGE

Ms Maria Ujfalusi

Swedish Environmental Protection Agency

Naturvårdsverket

Blekholmsterassen 36

S-106 48 Stockholm

UNITED KINGDOM

Mr Stephen Reeves

International Climate Change and Ozone Division

UK Dept of Environment, Food and Rural Affairs

3rd floor — zone 3/A3

Ashdown House

123 Victoria Street

London SW1E 6DE

United Kingdom